MedPath

Effect of Pilates Exercise Versus Circuit Exercise Training on Gestational Hypertension

Not Applicable
Recruiting
Conditions
Gestational Hypertension
Interventions
Drug: Anti-hypertensive drug (Methyldopa 250 mg)
Other: Pilates exercise
Other: Circuit exercise training
Registration Number
NCT06618521
Lead Sponsor
Cairo University
Brief Summary

The purpose of the study is to investigate the effect of Pilates exercises versus circuit exercise training on blood pressure and lipids in gestational hypertensive women.

Detailed Description

Gestational hypertension is one of the most common disorders seen in human pregnancies. The disorder progresses into pre-eclampsia, a dangerous condition that can prove fatal to expectant mothers. If it is untreated several complications result such as eclampsia, stroke, the need for labor induction and placental abruption, preterm delivery, and low birth weight.

Most pregnant women use medication during pregnancy despite increasing availability of information about teratogenic risks. Medication use during pregnancy still causes uncertainty and concern among pregnant women and their health care providers. Medication use has a harmful effect on the fetus such as congenital anomalies, preterm birth, low birth weight, growth retardation of the fetus, and developmental delays in totality. It remains unknown what the major concerns are among pregnant women regarding medication use.

Health organizations recommend lifestyle changes that include increased levels of physical activity. Also, some researchers have recommended aerobic training for 30 minutes per day that is supplemented with resistance exercise.

Pilates exercises have been showed to be safe modality for pregnant women. It showed many benefits on childbirth. It also yields a significant decrease in clinical systolic and diastolic and mean blood pressure at rest and over 24 hours, in hypertensive non-pregnant women. Pilates may be recommended as a non-drug intervention for the prevention, treatment, and control hypertension. Circuit exercise training is also a non-drug intervention may reduce systemic arterial hypertension to lower cardiovascular risk.

Due to the progressive increase in maternal estrogen with pregnancy, maternal fat deposits switch from anabolic to catabolic states to maintain appropriate development of the fetus and placenta. This switch to catabolism increases the breakdown of fat stores, which increases total cholesterol and triglyceride available for maternal and fetal utilization. Further, it is essential for a normalized maternal lipid profile to ensure healthy fetal development and pregnancy outcomes.

Therefore, this study will be conducted to provide evidence based for the effectiveness of Pilates exercise and circuit training on blood pressure and lipid profile in gestational hypertensive women for healthcare providers interested in women's health.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
69
Inclusion Criteria
  • They will be diagnosed by obstetrician after 20 weeks' gestation as having blood pressure higher than 140/90 without any organ damage.
  • Age will range from 25-35 years old .
  • Body mass index (BMI) will range from 30-34.9 Kg/m².
Exclusion Criteria
  • Cardiac problems
  • Cognitive problems
  • Poorly controlled hypertension
  • Diabetes mellitus
  • Inflammatory stage of arthritis
  • Osteoporosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Anti-hypertensive drugAnti-hypertensive drug (Methyldopa 250 mg)It consists of 23 pregnant women. They will take Anti-hypertensive drug (Methyldopa 250 mg according to physician instructions).
Anti-hypertensive drug + Pilates exerciseAnti-hypertensive drug (Methyldopa 250 mg)It consists of 23 pregnant women. They will be engaged in Pilates exercise for 40 minutes/day, 3 days/week, for 12 weeks, in addition to Anti-hypertensive drug (Methyldopa 250 mg according to physician instructions.
Anti-hypertensive drug + Pilates exercisePilates exerciseIt consists of 23 pregnant women. They will be engaged in Pilates exercise for 40 minutes/day, 3 days/week, for 12 weeks, in addition to Anti-hypertensive drug (Methyldopa 250 mg according to physician instructions.
Anti-hypertensive drug + Circuit exercise trainingAnti-hypertensive drug (Methyldopa 250 mg)It consists of 23 pregnant women. They will be engaged in a supervised circuit training exercises for 40 minutes/ day, 3 days/week, for 12 weeks, in addition to Anti-hypertensive drug (Methyldopa 250 mg according to physician instructions.
Anti-hypertensive drug + Circuit exercise trainingCircuit exercise trainingIt consists of 23 pregnant women. They will be engaged in a supervised circuit training exercises for 40 minutes/ day, 3 days/week, for 12 weeks, in addition to Anti-hypertensive drug (Methyldopa 250 mg according to physician instructions.
Primary Outcome Measures
NameTimeMethod
Measurement of blood pressure (BP)12 weeks

Pregnant women will sit in a relaxed position with the arm at rest on a table secure the cuff around the bicep so that it cannot move but is not tight squeeze the balloon to increase the pressure watch the aneroid monitor and increase the pressure to 20-30 mm higher than usual blood pressure after inflating the cuff, place the stethoscope just inside the elbow crease under the cuff deflated the balloon and listen to the sounds, known as Korotkoff sounds, through the stethoscope note the number on the aneroid monitor when the first sound occurs, as this systolic pressure continue listening until the steady heartbeat sound stops at this point, doctor record the number from the aneroid monitor which is the diastolic pressure. The BP will be measured for each pregnant women in the three groups before and after the end of the treatment procedures by using blood pressure device.

Assessment of serum triglycerides level12 weeks

It will be assessed for each pregnant women in the three groups before and after the end of the treatment procedures.The blood samples will be collected after fasting for 9-12 hours. Participants will be asked to lie in half lying position with well supported back and arm, the antecubital area will be cleaned with alcohol. Blood sample of about 5cm will be drawn in the morning (at 8 clock) range between 7and 25 micrograms per deciliter (mcg-dl). Blood sample will be using disposable syringe and collected in sterilized tube.

Assessment of serum total cholesterol level12 weeks

It will be assessed for each pregnant women in the three groups before and after the end of the treatment procedures.The blood samples will be collected after fasting for 9-12 hours. Participants will be asked to lie in half lying position with well supported back and arm, the antecubital area will be cleaned with alcohol. Blood sample of about 5cm will be drawn in the morning (at 8 clock) range between 7and 25 micrograms per deciliter (mcg-dl). Blood sample will be using disposable syringe and collected in sterilized tube.

Assessment of serum low-density lipoprotein (LDL) level12 weeks

It will be assessed for each pregnant women in the three groups before and after the end of the treatment procedures.The blood samples will be collected after fasting for 9-12 hours. Participants will be asked to lie in half lying position with well supported back and arm, the antecubital area will be cleaned with alcohol. Blood sample of about 5cm will be drawn in the morning (at 8 clock) range between 7and 25 micrograms per deciliter (mcg-dl). Blood sample will be using disposable syringe and collected in sterilized tube.

Assessment of serum high-density lipoprotein (HDL) level12 weeks

It will be assessed for each pregnant women in the three groups before and after the end of the treatment procedures.The blood samples will be collected after fasting for 9-12 hours. Participants will be asked to lie in half lying position with well supported back and arm, the antecubital area will be cleaned with alcohol. Blood sample of about 5cm will be drawn in the morning (at 8 clock) range between 7and 25 micrograms per deciliter (mcg-dl). Blood sample will be using disposable syringe and collected in sterilized tube.

Secondary Outcome Measures
NameTimeMethod
Assessment of level of stress and anxiety12 weeks

Visual analogue scale (VAS) will be used to assess the level of stress and anxiety for each pregnant woman in the three groups. VAS is a straight line; its ends are defined as the extreme limits of stress, with 0 indicates no stress and anxiety, while 10 indicates maximum stress and anxiety. The pregnant woman will select and marks on the line the suitable description of her stress level before and after the end of the treatment course.

Assessment of serum cortisol level12 weeks

It will be assessed for each pregnant women in the three groups before and after the end of the treatment procedures.The blood samples will be collected after fasting for 9-12 hours. Participants will be asked to lie in half lying position with well supported back and arm, the antecubital area will be cleaned with alcohol. Blood sample of about 5cm will be drawn in the morning (at 8 clock) range between 7and 25 micrograms per deciliter (mcg-dl). Blood sample will be using disposable syringe and collected in sterilized tube.

Trial Locations

Locations (1)

Cairo University

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath